Wockhardt Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of SEBI ....
WOCKPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Wockhardt Ltd has informed the exchanges that its Board of Directors will meet on Tuesday, 10th February 2026. The main agenda is to consider and approve the unaudited financial results (both standalone and consolidated) for the quarter and nine months ended 31st December 2025. The trading window for dealing in the company's shares remains closed from 1st January 2026 until 48 hours after the results are declared. This is a routine regulatory intimation and no financial numbers have been disclosed yet.
No immediate impact on shareholders or stock price — this is a standard advance notice ahead of the Q3 FY26 earnings release. Investors should watch for the actual results on 10th February 2026 for any meaningful update on the pharma company's performance.